Skip to content
INTERNATIONAL · DAILY NEWS & INTELLIGENCEAbout
Frankly NewsIndependent Global News & Real-time Analysis.
EditionInternational
HomeHealth

Health01

A common osteoporosis drug blocked spinal damage in a surprising new study

Scientists have identified a surprising genetic link to spinal degeneration, finding that an existing osteoporosis drug can prevent damaging mineral buildu...

01HealthFN
Editorial illustration, not a photo of the event.

Scientists have identified a surprising genetic link to spinal degeneration, finding that an existing osteoporosis drug can prevent damaging mineral buildup in the spines of zebrafish. The research, reported in the health category, suggests the medication may interrupt a process that contributes to a leading cause of chronic back pain. In laboratory experiments, treated fish showed reduced calcification in spinal tissues compared with untreated controls, according to the findings. The mechanism appears tied to a gene involved in regulating mineral deposition, though researchers caution that the pathway has not yet been confirmed in humans.

The discovery could open a new avenue for therapies aimed at slowing or preventing spinal degeneration, a condition that affects millions worldwide and is a major driver of disability and lost productivity. Because the drug is already approved for osteoporosis, it may offer a faster route to clinical testing than a novel compound, though experts stress that animal results frequently fail to translate to people. Further studies are needed to determine whether the same protective effect occurs in humans and whether long-term use carries risks. The team has not announced a timeline for follow-up trials.

Independent reporting synthesized from primary wires and global correspondents.